Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(12)
•••
Comment by quietobserveron Sep 10, 2019 5:23pm
138 Views
Post# 30114400

RE:RE:RE:8 Aphria insiders got grant of rights deferred shares sep 5

RE:RE:RE:8 Aphria insiders got grant of rights deferred shares sep 5 Hi Humanist. Kenser answered the question. It looks like some kind of top up to their salary but interesting enough the same group got 4199 deferred units 3 months before but they say "public market buy", not "rights granted" Maybe this is a quarterly bonus? We'll have to look at Nov 30th to confirm whether it is a quarterly thing.
Humanist wrote: thx Quietobserver. what do you make of the timing.. do you think it has something to do with something coming soon, and they're granting them just before...?


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities